Skip to main content

JANSSEN BIOTECH INC v. CELLTRION HEALTHCARE CO LTD (2020)

United States Court of Appeals, Federal Circuit.

JANSSEN BIOTECH, INC., Plaintiff-Appellant v. CELLTRION HEALTHCARE CO., LTD., Celltrion, Inc., Hospira, Inc., Defendants-Cross-Appellants

2018-2321, 2018-2350

Decided: March 05, 2020

(Wallach, Taranto, and Stoll, Circuit Judges). Gregory Diskant, Patterson Belknap Webb & Tyler LLP, New York, NY, argued for plaintiff-appellant. Also represented by Andrew D. Cohen, Aron Russell Fischer, Eugene M. Gelernter. James F. Hurst, Kirkland & Ellis LLP, Chicago, IL, argued for defendants-cross-appellants. Also represented by Bryan Scott Hales; William H. Burgess, John C. O'Quinn, Washington, DC.

JUDGMENT

THIS CAUSE having been heard and considered, it is Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.

Per Curiam

Was this helpful?

Thank you. Your response has been sent.

Welcome to FindLaw's Cases & Codes

A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes visit FindLaw's Learn About the Law.

Go to Learn About the Law
JANSSEN BIOTECH INC v. CELLTRION HEALTHCARE CO LTD (2020)

Docket No: 2018-2321, 2018-2350

Decided: March 05, 2020

Court: United States Court of Appeals, Federal Circuit.

Get a profile on the #1 online legal directory

Harness the power of our directory with your own profile. Select the button below to sign up.

Sign up

Learn About the Law

Get help with your legal needs

FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.

Learn more about the law
Copied to clipboard